Drospirenone

Overview

Drospirenone is a synthetic progestin used in oral contraceptive pills. It is characterized by its ability to mimic the natural hormone progesterone and also possesses anti-androgenic and slight anti-mineralocorticoid properties.

API suppliers (16)

Suppliers of Drospirenone backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• NEWCHEM SPA2 active DMF
• Gedeon RichterHungary1 active DMF
• STERLING SPAItaly1 active DMF
• INDUSTRIALE CHIMICA SRLItaly1 active DMF
• STERLING SPAItaly1 active DMF
• INDUSTRIALE CHIMICA SRLItaly1 active DMF
• Gedeon RichterHungary1 active DMF
• TAPI NL BV1 active DMF
• INDUSTRIALE CHIMICA SRLItaly1 active DMF
• STERLING SPAItaly1 active DMF
• Gedeon RichterHungary1 active DMF
• INDUSTRIALE CHIMICA SRLItaly1 active DMF
• STERLING SPAItaly1 active DMF
• TAPI NL BV1 active DMF
• Lupin LimitedIndia1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Drospirenone expires 27 Jun 2031. Generic API sourcing typically opens up once these lapse.

Therapeutic areas